Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antipsychotic Induced Weight Gain”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Post-approval studies (Phase 4)Ended earlyNCT01844700
What this trial is testing

1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain

Who this might be right for
High Risk MC4R GenotypeLow Risk MC4R GenotypeOne Week or Less Antipsychotic Lifetime Exposure
Northwell Health 14
Early research (Phase 1)Study completedNCT03877562
What this trial is testing

The Effect of CORT118335 on Olanzapine-Induced Weight Gain

Who this might be right for
Antipsychotic-induced Weight Gain
Corcept Therapeutics 96
Post-approval studies (Phase 4)Looking for participantsNCT06740890
What this trial is testing

Exercise and Olanzapine-samidorphan

Who this might be right for
Schizophenia DisorderSchizoaffective DisorderBipolar Disorder I or II+1 more
New York State Psychiatric Institute 30
Not applicableStudy completedNCT02281162
What this trial is testing

The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain

Who this might be right for
SchizophreniaMetabolic SyndromeVitamin D Deficiency
Creighton University 20
Not applicableStudy completedNCT00474227
What this trial is testing

Proper Nutrition, Physical Exercise and Appropriate Weight in Individuals With Long Term Mental Illness

Who this might be right for
Obesity
Lev-Hasharon Mental Healtlh Center 50
Testing effectiveness (Phase 2)Study completedNCT04524403
What this trial is testing

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

Who this might be right for
Antipsychotic-induced Weight Gain (AIWG)
Corcept Therapeutics 150
Post-approval studies (Phase 4)Study completedNCT00191828
What this trial is testing

A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme

Who this might be right for
Weight Gain
Eli Lilly and Company 60
Large-scale testing (Phase 3)Looking for participantsNCT06936137
What this trial is testing

: EFFECT OF PROBIOTIC SUPPLEMENTATION ON ATYPICAL ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN PATIENTS ATTENDING PSYCHIATRIC CLINICS AT AINSHAMS UNIVERSITY HOSPITALS (A RANDOMIZED CONTROLLED TRIAL)

Who this might be right for
Antipsychotic Induced Weight Gain
Ain Shams University 180
Large-scale testing (Phase 3)Looking for participantsNCT07606014
What this trial is testing

No Guts No Glory Probiotics

Who this might be right for
Patients Using Olanzapine, Quetiapine, Risperidone or Clozapine
University Medical Center Groningen 112
Not applicableNot Yet RecruitingNCT07795554
What this trial is testing

The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain

Who this might be right for
Schizophrenia SpectrumSchizophreniaAntipsychotic Induced Weight Gain
Second Xiangya Hospital of Central South University 60
Not applicableStudy completedNCT01075295
What this trial is testing

Prevention of Weight Gain in Early Psychoses

Who this might be right for
Schizophreniform DisorderBipolar I DisorderBipolar II Disorder+5 more
Centre for Addiction and Mental Health 70
Post-approval studies (Phase 4)Looking for participantsNCT05744479
What this trial is testing

Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability

Who this might be right for
Intellectual DisabilityDevelopmental DisabilityObesity
Centre for Addiction and Mental Health 100
Not applicableLooking for participantsNCT06729671
What this trial is testing

A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction

Who this might be right for
Psychosis
University College Cork 70
Large-scale testing (Phase 3)Not Yet RecruitingNCT07770282
What this trial is testing

Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome

Who this might be right for
Schizophrenia DisorderMetabolic SyndromeAntipsychotic-induced Weight Gain+2 more
All India Institute of Medical Sciences, Bhubaneswar 600
Post-approval studies (Phase 4)Study completedNCT00816907
What this trial is testing

The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)

Who this might be right for
Schizophrenia
National Institute of Mental Health (NIMH) 146
Early research (Phase 1)Study completedNCT05712265
What this trial is testing

Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant

Who this might be right for
Antipsychotic Induced Weight GainNon-alcoholic Steatohepatitis (NASH)
Corcept Therapeutics 26
Post-approval studies (Phase 4)Not Yet RecruitingNCT07342764
What this trial is testing

Dapagliflozin Versus Metformin for the Management of Antipsychotic-Induced Weight Gain: A Pragmatic Pilot Randomized Controlled Trial

Who this might be right for
Antipsychotic-induced Weight Gain (AIWG)Antipsychotic-induced Weight Gain
Sultan Qaboos University 110
Testing effectiveness (Phase 2)Study completedNCT00617240
What this trial is testing

Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth

Who this might be right for
Weight Gain
University of North Carolina, Chapel Hill 9
Post-approval studies (Phase 4)UnknownNCT00541554
What this trial is testing

Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia

Who this might be right for
HyperprolactinemiaWeight GainDyslipidemia
Genovate Biotechnology Co., Ltd.,
Early research (Phase 1)Study completedNCT05857566
What this trial is testing

Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine

Who this might be right for
Drug-induced Weight Gain
Response Pharmaceuticals 24
Next Page